These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

372 related items for PubMed ID: 17328584

  • 21. Concurrent assessment of hepatic and intestinal cytochrome P450 3A activities using deuterated alfentanil.
    Kharasch ED, Vangveravong S, Buck N, London A, Kim T, Blood J, Mach RH.
    Clin Pharmacol Ther; 2011 Apr; 89(4):562-70. PubMed ID: 21346758
    [Abstract] [Full Text] [Related]

  • 22. Docetaxel pharmacokinetics and its correlation with two in vivo probes for cytochrome P450 enzymes: the C(14)-erythromycin breath test and the antipyrine clearance test.
    Michael M, Cullinane C, Hatzimihalis A, O'Kane C, Milner A, Booth R, Schlicht S, Clarke SJ, Francis P.
    Cancer Chemother Pharmacol; 2012 Jan; 69(1):125-35. PubMed ID: 21626050
    [Abstract] [Full Text] [Related]

  • 23. Elimination of alfentanil delivered by infusion is not altered by the chronic administration of atorvastatin.
    McDonnell CG, Malkan D, Van Pelt FD, Shorten GD.
    Eur J Anaesthesiol; 2003 Aug; 20(8):662-7. PubMed ID: 12932070
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Physiology-based simulations of a pathological condition: prediction of pharmacokinetics in patients with liver cirrhosis.
    Edginton AN, Willmann S.
    Clin Pharmacokinet; 2008 Aug; 47(11):743-52. PubMed ID: 18840029
    [Abstract] [Full Text] [Related]

  • 26. Effect of the CYP3A4 inhibitor erythromycin on the pharmacokinetics of lignocaine and its pharmacologically active metabolites in subjects with normal and impaired liver function.
    Orlando R, Piccoli P, De Martin S, Padrini R, Palatini P.
    Br J Clin Pharmacol; 2003 Jan; 55(1):86-93. PubMed ID: 12534644
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Pharmacokinetics and dosage adjustment in patients with hepatic dysfunction.
    Verbeeck RK.
    Eur J Clin Pharmacol; 2008 Dec; 64(12):1147-61. PubMed ID: 18762933
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Elimination of intravenous oxycodone in the elderly: a pharmacokinetic study in postoperative orthopaedic patients of different age groups.
    Liukas A, Kuusniemi K, Aantaa R, Virolainen P, Neuvonen M, Neuvonen PJ, Olkkola KT.
    Drugs Aging; 2011 Jan 01; 28(1):41-50. PubMed ID: 21174486
    [Abstract] [Full Text] [Related]

  • 33. Effect of moderate or severe liver dysfunction on the pharmacokinetics of gamma-hydroxybutyric acid.
    Ferrara SD, Tedeschi L, Frison G, Orlando R, Mazzo M, Zordan R, Padrini R, Palatini P.
    Eur J Clin Pharmacol; 1996 Jan 01; 50(4):305-10. PubMed ID: 8803524
    [Abstract] [Full Text] [Related]

  • 34. Alfentanil pharmacokinetics in patients with cirrhosis.
    Ferrier C, Marty J, Bouffard Y, Haberer JP, Levron JC, Duvaldestin P.
    Anesthesiology; 1985 Apr 01; 62(4):480-4. PubMed ID: 3920934
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Effect of mild and moderate hepatic impairment on the pharmacokinetics and safety of carisbamate.
    Moore K, Zannikos P, Solanki B, Greenspan A, Verhaeghe T, Brashear HR.
    J Clin Pharmacol; 2012 May 01; 52(5):738-46. PubMed ID: 21566203
    [Abstract] [Full Text] [Related]

  • 39. Pharmacokinetics of levetiracetam in patients with moderate to severe liver cirrhosis (Child-Pugh classes A, B, and C): characterization by dynamic liver function tests.
    Brockmöller J, Thomsen T, Wittstock M, Coupez R, Lochs H, Roots I.
    Clin Pharmacol Ther; 2005 Jun 01; 77(6):529-41. PubMed ID: 15961984
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 19.